Evolution of bosutinib (BOS) toxicity in patients (pts) with Ph+ leukemia after resistance/intolerance to prior therapy. This is an ASCO Meeting Abstract from the 2013 ASCO Annual Meeting I. This ...
Incidence of colorectal premalignant and malignant neoplasm on colonoscopy in an in-patient setting. Bevacizumab (Bev) with or without erlotinib as maintenance therapy, following induction first-line ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results